Intensified Chemotherapy in CRC After Resection of Liver Metastases

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

April 30, 2004

Study Completion Date

August 31, 2007

Conditions
Colorectal CancerLiver MetastasesChemotherapy
Interventions
DRUG

FOLFIRI

FOLFIRI : Irinotecan : 180 mg/m² 90 min continuous perfusion during levorin d1 every 2 weeks

DRUG

FOLFOX-4

FOLFOX 4 : Oxaliplatine : 85 mg/m² 2h continuous perfusion during levorin d1 every 2weeks

DRUG

FOLFIRI-HD

High Dose FOLFIRI : Irinotecan : 260 mg/m² in 90min continuous perfusion during levorin d1 every 2 weeks

DRUG

FOLFOX-7

FOLFOX 7 : Oxaliplatine : 130 mg/m² in 2h continuous perfusion during levorin d1 every 2 weeks

DRUG

FOLFIRINOX

FOLFIRINOX : Oxaliplatine : 85 mg/m² 2h continuous perfusion followed by 1H rest followed by 90 min continuous perfusion of irinotecan : 180 mg/m² during levorin d1 every 2 weeks

Trial Locations (1)

34298

CRLC Val d'Aurelle, Montpellier

Sponsors
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

collaborator

Sanofi

INDUSTRY

collaborator

Chugai Pharmaceutical

INDUSTRY

lead

Institut du Cancer de Montpellier - Val d'Aurelle

OTHER